Evidence map›Paper›PMID 36231033›Full record

ArticleCells2022

Increased Adipose Tissue Expression of IL-23 Associates with Inflammatory Markers in People with High LDL Cholesterol.

Shihab Kochumon, Amal Hasan, Fatema Al-Rashed, Sardar Sindhu, Reeby Thomas, Texy Jacob, Amnah Al-Sayyar, Hossein Arefanian, Ashraf Al Madhoun, Ebaa Al-Ozairi and 5 more

Open access · goldAbstract read
In one paragraph

Article in Cells, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 1 pooled it
1.8field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 1 synthesis or guideline pooled it, 21 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. The Role of Adipokines in the Pathogenesis of Psoriasis.International journal of molecular sciences · 2023
    Review
  12. Article
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 3 institutions in 3 countries.

Shihab KochumonDepartment of Immunology & Microbiology, Dasman Diabetes Institute, Dasman 15462, Kuwait.
Amal HasanDepartment of Immunology & Microbiology, Dasman Diabetes Institute, Dasman 15462, Kuwait.ORCID 0000-0002-1793-7794
Fatema Al-RashedDepartment of Immunology & Microbiology, Dasman Diabetes Institute, Dasman 15462, Kuwait.ORCID 0000-0002-5825-7701
Sardar SindhuAnimal and Imaging Core Facilities, Dasman Diabetes Institute, Dasman 15462, Kuwait.ORCID 0000-0001-9936-1575
Reeby ThomasDepartment of Immunology & Microbiology, Dasman Diabetes Institute, Dasman 15462, Kuwait.ORCID 0000-0001-9933-0285
Texy JacobDepartment of Immunology & Microbiology, Dasman Diabetes Institute, Dasman 15462, Kuwait.
Amnah Al-SayyarDepartment of Immunology & Microbiology, Dasman Diabetes Institute, Dasman 15462, Kuwait.ORCID 0000-0002-6854-0746
Hossein ArefanianDepartment of Immunology & Microbiology, Dasman Diabetes Institute, Dasman 15462, Kuwait.ORCID 0000-0001-6414-0916
Ashraf Al MadhounAnimal and Imaging Core Facilities, Dasman Diabetes Institute, Dasman 15462, Kuwait.ORCID 0000-0001-8593-3878
Ebaa Al-OzairiMedical Division, Dasman Diabetes Institute, Dasman 15462, Kuwait.
Fawaz AlzaidInstitut Necker Enfants Malades (INEM), French Institute of Health and Medical Research (INSERM), Immunity & Metabolism of Diabetes (IMMEDIAB), Université de Paris Cité, 75014 Paris, France.ORCID 0000-0003-3056-3640
Heikki A KoistinenDepartment of Medicine, Helsinki University Hospital, University of Helsinki, 00029 Helsinki, Finland.ORCID 0000-0001-7870-070X
Fahd Al-MullaDepartment of Genetics and Bioinformatics, Dasman Diabetes Institute, Dasman 15462, Kuwait.ORCID 0000-0001-5409-3829
Jaakko TuomilehtoDepartment of Public Health and Welfare, Finnish Institute for Health and Welfare, 00271 Helsinki, Finland.
Rasheed AhmadDepartment of Immunology & Microbiology, Dasman Diabetes Institute, Dasman 15462, Kuwait.ORCID 0000-0001-5746-0743
Dasman Diabetes Institute · KWUniversity of Helsinki · FIInserm · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Chronic low-grade inflammation induced by obesity is a central risk factor for the development of metabolic syndrome. High low-density lipoprotein cholesterol (LDL-c) induces inflammation, which is a common denominator in metabolic syndrome. IL-23 plays a significant role in the pathogenesis of meta-inflammatory diseases; however, its relationship with LDL-c remains elusive. In this cross-sectional study, we determined whether the adipose tissue IL-23 expression was associated with other inflammatory mediators in people with increased plasma LDL-c concentrations. Subcutaneous adipose tissue biopsies were collected from 60 people, sub-divided into two groups based on their plasma LDL-c concentrations (<2.9 and ≥2.9 mmol/L). Adipose expression of IL-23 and inflammatory markers were determined using real-time qRT-PCR; plasma concentrations of total cholesterol (TC), triglyceride (TG), high-density lipoprotein cholesterol (HDL-c) and LDL-c were determined using the standard method; and adiponectin levels were measured by enzyme-linked immunosorbent assay (ELISA). Adipose IL-23 transcripts were found to be increased in people with high LDL-c, compared to low LDL-c group (H-LDL-c: 1.63 ± 0.10-Fold; L-LDL-c: 1.27 ± 0.09-Fold;

Indexed as

HyperlipidemiasMetabolic SyndromeAdiponectinAdipose TissueBiomarkersChemokinesCholesterolCholesterol, HDLCholesterol, LDLCross-Sectional StudiesCytokinesHumansInflammationInflammation MediatorsInterleukin-12Interleukin-18AdiponectinBiomarkersChemokinesCholesterolCholesterol, HDLCholesterol, LDLCytokinesIL23A protein, humanInflammation MediatorsInterleukin-12Interleukin-18Interleukin-23Interleukin-23 Subunit p19Toll-Like Receptor 8TriglyceridesTumor Necrosis Factor-alphaadipose tissuecytokines/chemokinesIL-23inflammationLDL-cholesterol

Identifiers

PMID36231033
PMCPMC9563604
OpenAlexW4297988970

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.